<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Pediatr Radiol</journal-id>
      <journal-title>Pediatric Radiology</journal-title>
      <issn pub-type="ppub">0301-0449</issn>
      <issn pub-type="epub">1432-1998</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">17710390</article-id>
      <article-id pub-id-type="pmc">2292491</article-id>
      <article-id pub-id-type="publisher-id">567</article-id>
      <article-id pub-id-type="doi">10.1007/s00247-007-0567-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>MRI evaluation of tissue iron burden in patients with &#x3B2;-thalassaemia major</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Argyropoulou</surname>
            <given-names>Maria I.</given-names>
          </name>
          <address>
            <email>margyrop@cc.uoi.gr</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Astrakas</surname>
            <given-names>Loukas</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">Radiology Department, Medical School, University of Ioannina, Ioannina, GR-45110 Greece </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>8</month>
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2007</year>
      </pub-date>
      <volume>37</volume>
      <issue>12</issue>
      <fpage>1191</fpage>
      <lpage>1200</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>2</month>
          <year>2007</year>
        </date>
        <date date-type="rev-recd">
          <day>7</day>
          <month>5</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>5</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Springer-Verlag 2007</copyright-statement>
      </permissions>
      <abstract>
        <p>&#x3B2;-Thalassaemia major is a hereditary haemolytic anaemia that is treated with multiple blood transfusions. A major complication of this treatment is iron overload, which leads to cell death and organ dysfunction. Chelation therapy, used for iron elimination, requires effective monitoring of the body burden of iron, for which serum ferritin levels and liver iron content measured in liver biopsies are used as markers, but are not reliable. MRI based on iron-induced T2 relaxation enhancement can be used for the evaluation of tissue siderosis. Various MR protocols using signal intensity ratio and mainstream relaxometry methods have been used, sometimes with discrepant results. Relaxometry methods using multiple echoes achieve better sampling of the time domain in which relaxation mechanisms take place and lead to more precise results. In several studies the MRI parameters of liver siderosis have failed to correlate with those of other affected organs, underlining the necessity for MRI iron evaluation in individual organs. Most studies have included children in the evaluated population, but MRI data on very young children are lacking. Wider application of relaxometry methods is indicated, with the establishment of universally accepted MRI protocols, and further studies, including young children, are needed.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>&#x3B2;-Thalassaemia</kwd>
        <kwd>MRI</kwd>
        <kwd>Iron</kwd>
        <kwd>Relaxometry</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag 2007</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>&#x3B2;-Thalassaemia major is a hereditary anaemia characterized by ineffective erythropoiesis and haemolysis [<xref ref-type="bibr" rid="CR1">1</xref>]. The underlying mechanism is defective production of haemoglobin &#x3B2;-chains, resulting in excess of &#x3B1;-chains, which are unstable and precipitate to form intracellular inclusion bodies [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. This excessive intracellular deposition of &#x3B1;-chain material is responsible for accelerated apoptosis of the erythroid precursors and for peripheral haemolysis of the erythrocytes [<xref ref-type="bibr" rid="CR3">3</xref>]. By the age of 3&#xA0;months, severe anaemia develops leading to increased intestinal iron absorption. To maintain haemoglobin at a level of 10&#x2013;12&#xA0;g/dl, patients suffering from &#x3B2;-thalassaemia major need to be given repeated blood transfusions [<xref ref-type="bibr" rid="CR1">1</xref>]. A major drawback of this treatment is transfusion siderosis, which, in association with the increased intestinal iron absorption, apoptosis of the erythroid precursors and peripheral haemolysis, leads to iron overload [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
      <p>Iron is ubiquitous in eukaryotic organisms. It is essential for cellular survival and proliferation and for haemoglobin synthesis [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Human demands for iron are covered partly by intestinal absorption, but mainly from the recycling of iron from old or abnormal erythrocytes phagocytized by macrophages [<xref ref-type="bibr" rid="CR6">6</xref>]. Iron released from macrophages binds mainly to transferrin, but also to citrate and albumin to form non-transferrin-bound iron (NTBI) which is a toxic form [<xref ref-type="bibr" rid="CR7">7</xref>&#x2013;<xref ref-type="bibr" rid="CR9">9</xref>]. Extracellular iron bound to transferrin enters the cell via transferrin receptors by a process of endocytosis. Once iron is released into the cytoplasm, it enters a poorly defined cellular compartment termed the labile iron pool (LIP). Iron in this compartment is loosely bound and therefore is highly toxic [<xref ref-type="bibr" rid="CR10">10</xref>]. Intracellular iron that is not needed for immediate use is stored in the form of ferritin which consists of an apoprotein storing up to 4,500 atoms of iron (loading factor 4,500) [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR11">11</xref>], and is not cytotoxic. When ferritin storage capacity is exceeded the LIP increases and haemosiderin is generated from ferritin denaturation [<xref ref-type="bibr" rid="CR10">10</xref>]. Iron in the form of haemosiderin is thought to be more cytotoxic [<xref ref-type="bibr" rid="CR10">10</xref>]. The iron in the LIP is in both the ferrous (Fe<sup>2+</sup>) and ferric (Fe<sup>3+</sup>) forms [<xref ref-type="bibr" rid="CR12">12</xref>]. Fe<sup>2+</sup> reacts with hydrogen and lipid peroxides and generates highly toxic hydroxyl and lipid radicals (Fenton reaction) that damage cellular membranes, proteins and nucleic acids [<xref ref-type="bibr" rid="CR4">4</xref>]. Iron overload, just as lack of cellular iron, may lead to cell death and organ dysfunction.</p>
      <p>Iron overload is a major cause of morbidity and mortality in &#x3B2;-thalassaemia major [<xref ref-type="bibr" rid="CR1">1</xref>]. Iron accumulates initially in the reticuloendothelial system (bone marrow, spleen, liver) and then in the hepatocytes, the heart (myocytes) and the endocrine glands [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. In contrast to the reticuloendothelial cells, the turnover of iron in the hepatocytes, myocytes and endocrine glands is very low [<xref ref-type="bibr" rid="CR9">9</xref>]. Chelation therapy has been used to eliminate excess iron [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Chelatable iron is derived from the catabolism of haemoglobin in macrophages [<xref ref-type="bibr" rid="CR14">14</xref>]. Chelators remove NTBI from the plasma, but they do not interact with ferritin and haemosiderin at clinically relevant rates [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Desferrioxamine (DFO), which is the chelating agent most widely used over the last 30&#xA0;years, requires parenteral administration. It removes mainly extracellular iron and only a fraction of the intracellular LIP iron [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Deferiprone is an oral iron chelator that penetrates the cellular membrane and chelates intracellular species of toxic iron [<xref ref-type="bibr" rid="CR16">16</xref>]. Cellular uptake of chelators takes place at different rates in different cells [<xref ref-type="bibr" rid="CR15">15</xref>]. DFO is of low toxicity, mainly affecting the optic, auditory and skeletal systems [<xref ref-type="bibr" rid="CR7">7</xref>]. Skeletal changes develop mainly due to the toxic effects of DFO on the growth cartilage and are manifested as disproportionate truncal shortening with loss of seated height [<xref ref-type="bibr" rid="CR7">7</xref>]. Adverse effects of deferiprone are arthralgia, gastrointestinal symptoms, elevated liver enzymes and rarely agranulocytosis [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR16">16</xref>].</p>
      <p>The effective management of patients, and especially of children, with thalassaemia requires optimal monitoring of the toxic effects of both iron overload and excessive chelation therapy. Serum ferritin has been widely used as a surrogate marker and a target ferritin level of 1,000&#xA0;&#x3BC;g/l is generally recommended [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. However, serum ferritin represents only 1% of the total iron pool, and as an acute-phase protein it is not specific because the levels can be raised in inflammation (e.g. hepatitis) and liver damage [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Chronic liver inflammation is not rare in patients with thalassaemia, since over 40% of them have positive anti-hepatitis C virus (HCV) antibodies and more than 50% have chronic (persistent or active) hepatitis [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. Liver iron concentration (LIC) measured on needle biopsy is currently considered the gold standard for the evaluation of siderosis [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. However, needle biopsy is an invasive technique, it is not easily repeatable and the accuracy of the resulting LIC measurement is greatly affected by hepatic inflammation-fibrosis and uneven iron distribution [<xref ref-type="bibr" rid="CR22">22</xref>]. Furthermore, it appears that cardiac iron overload, which is the leading cause of death in thalassaemia, cannot be predicted from the degree of liver siderosis, probably because of differences in iron kinetics between liver and heart cells [<xref ref-type="bibr" rid="CR9">9</xref>]. The use of non-invasive techniques for monitoring iron overload in each of the affected organs would be preferable, and to this end MRI has been used increasingly over the last two decades [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR22">22</xref>&#x2013;<xref ref-type="bibr" rid="CR44">44</xref>]. Other non-invasive methodologies are too complex, too costly and not readily available (i.e. magnetic susceptometry), or lack imaging capability (i.e. magnetic resonance spectroscopy) [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>].</p>
    </sec>
    <sec id="Sec2">
      <title>MRI assessment of tissue iron</title>
      <sec id="Sec3">
        <title>Relaxation theories</title>
        <p>MRI evaluation of tissue iron overload is based on T2 relaxation enhancement induced from the interactions between high-molecular-weight iron complexes such as ferritin, haemosiderin and ferrioxamine with water molecules [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. Ferrioxamine is produced after cellular uptake of DFO, and in extrahepatic tissues, where there is no active excretion and it may remain for days [<xref ref-type="bibr" rid="CR7">7</xref>]. Ferrioxamine-based agents have been used in the past as contrast media because of their T2* effect [<xref ref-type="bibr" rid="CR49">49</xref>]. &#x201C;Inner sphere&#x201D; and &#x201C;outer sphere&#x201D; relaxation theories have been proposed to explain the T2 relaxation enhancement induced in siderotic tissues [<xref ref-type="bibr" rid="CR50">50</xref>&#x2013;<xref ref-type="bibr" rid="CR55">55</xref>]. According to the inner sphere theory, iron electron spins enhance the relaxation of protons of water molecules buried in iron-containing proteins. Enhanced relaxation of the bound water protons is then transferred to the free water protons by water or proton exchange [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. According to the outer sphere theory, magnetic field gradients induced at the periphery of iron-containing proteins create loss of phase and relaxation enhancement of free water protons diffusing in the neighbourhood [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>].</p>
      </sec>
      <sec id="Sec4">
        <title>MR methodologies</title>
        <p>MR methods for assessing tissue iron can be separated into two groups: signal intensity ratio (SIR) methods and relaxometry methods. Various techniques have been described, including: (a) methods measuring SIR based on T2-weighted (spin-echo) or T2*-weighted (gradient-echo) sequences [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR23">23</xref>&#x2013;<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR58">58</xref>&#x2013;<xref ref-type="bibr" rid="CR62">62</xref>], (b) relaxometry methods measuring absolute T2, (c) relaxometry methods measuring absolute T2*, and (d) hybrid relaxometry methods [<xref ref-type="bibr" rid="CR30">30</xref>&#x2013;<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR34">34</xref>&#x2013;<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR39">39</xref>&#x2013;<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR63">63</xref>].</p>
        <sec id="Sec5">
          <title>SIR methods</title>
          <p>These have been used for the study not only of the liver but also of other organs such as the spleen, pancreas, pituitary gland, bone marrow and abdominal lymph nodes [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR58">58</xref>&#x2013;<xref ref-type="bibr" rid="CR62">62</xref>]. For SIR assessment the signal intensity of the target organ is divided by the signal intensity of a reference tissue (e.g. fat, muscle) or noise. Signal intensity measurements are performed in the same slice by using the region-of-interest (ROI) method. For large organs such the liver, spleen and pancreas more than one ROI is used, positioned in areas lacking vascular structures and movement artefacts [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. The mean signal intensity from the different ROIs is then divided by the signal intensity of the reference tissue. One ROI is used for signal intensity measurement of the pituitary gland, bone marrow, abdominal lymph nodes and the reference tissue [<xref ref-type="bibr" rid="CR58">58</xref>&#x2013;<xref ref-type="bibr" rid="CR60">60</xref>]. For SIR evaluation of the liver various reference tissues have been used, of which paraspinal muscle appears to be the best choice because it combines good sensitivity with minimum intersite variability [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. A disadvantage of the SIR methods is that in most cases they use only one echo time (TE) and thus lose their detection sensitivity in tissues with heavy siderosis, where transverse relaxation is much faster than the TE. This occurs particularly in the liver at the upper range of LIC values where signal intensities are widely dispersed [<xref ref-type="bibr" rid="CR39">39</xref>]. Gandon et al. [<xref ref-type="bibr" rid="CR19">19</xref>], by using an algorithm that combined signal intensity ratios from multiple sequences with different TEs, achieved extension of the detection range up to about 21&#xA0;mg Fe per gram dry liver tissue, with sensitivity and specificity similar to those of biochemical analysis.</p>
        </sec>
        <sec id="Sec6">
          <title>T2 relaxometry methods</title>
          <p>These assess T2 relaxation time or R2 (1/T2) by using the Carr-Purcell-Meiboom-Gill (CPMG) spin-echo sequence, which employs multiple (2&#x2013;32) equidistant refocusing 180&#xB0; pulses, each followed by an echo [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. Most scanners, by using a pixel-by-pixel, log-linear fitting model, automatically derive the corresponding T2 maps. Signal intensity measurements in the T2 maps correspond to the mean T2 relaxation time of the included voxels [<xref ref-type="bibr" rid="CR67">67</xref>]. To avoid motion artefacts from respiration, studies of abdominal organs should be performed with respiratory triggering. To this end a pressure-sensitive pad is attached to the abdomen and depending on the patient&#x2019;s respiratory cycle a delay time is chosen. Data acquisition takes place at the end-expiration phase [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. During cardiac MRI, in addition to respiratory triggering, cardiac triggering is necessary. To obtain a minimum repetition time (TR) of 2,000&#xA0;ms two to three R&#x2013;R intervals should be allowed between successive excitations [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. The mid-systole phase and a cardiac trigger delay of around 250&#x2013;300&#xA0;ms are usually chosen to image the myocardium with sufficient thickness for the best signal intensity measurements [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. A pseudo four-chamber or short-axis view of the heart is generally used. A T2 relaxometry method that received FDA approval for clinical liver iron estimation has recently been developed by St. Pierre et al. [<xref ref-type="bibr" rid="CR44">44</xref>]. This method uses multiple T2-weighted single spin-echo sequences with different TEs acquired in half-Fourier mode to reduce acquisition time. The calculated mean R2 values combined with LIC values, obtained from liver biopsies, are used to create calibration curves.</p>
        </sec>
        <sec id="Sec7">
          <title>T2* relaxometry methods</title>
          <p>These evaluate T2* or R2* (1/T2*) by using multiple gradient-echo sequences with different TEs. These methods have been developed to further accelerate acquisition, in order to increase sensitivity and eliminate artefacts related to respiration or cardiac motion. To obtain R2* (1/T2*) values, the signal decay curve is usually fitted with an exponential model: S=S<sub>0</sub>e<sup>&#x2212;TE/T2*</sup>, where S is the net image signal intensity, TE is the echo time and S<sub>0</sub> is a constant [<xref ref-type="bibr" rid="CR68">68</xref>]. T2* relaxometry methods have been used mainly for myocardial iron assessment and cardiac gating is always applied [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR68">68</xref>&#x2013;<xref ref-type="bibr" rid="CR71">71</xref>]. Breath-hold sequences have greatly eliminated motion artefacts [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR68">68</xref>].</p>
        </sec>
        <sec id="Sec8">
          <title>Hybrid relaxometry methods</title>
          <p>Hybrid approaches have been applied in high fields and measure both R2 and R2* to calculate the inhomogeneity factor R2&#x2032;=R2*&#x2212;R2 [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>]. These approaches assume that R2&#x2032; is more specific to mechanisms of relaxation related to iron than R2 [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR73">73</xref>].</p>
        </sec>
      </sec>
      <sec id="Sec9">
        <title>Comparison of the MRI methodologies</title>
        <sec id="Sec10">
          <title>SIR versus relaxometry</title>
          <p>SIR methods require shorter acquisition times but lack a wide range of iron assessment [<xref ref-type="bibr" rid="CR63">63</xref>]. Relaxometry methods, mainly the T2* method, by using multiple echoes create in- and out-of-phase effects between water and fat transverse magnetization (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>) [<xref ref-type="bibr" rid="CR35">35</xref>]. Relaxometry methods, although taking longer, are preferable because they achieve a better sampling of the time domain in which relaxation mechanisms take place and lead to more precise results [<xref ref-type="bibr" rid="CR63">63</xref>].
<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>A 15-year-old male with &#x3B2;-thalassaemia major. Axial scan with a multiecho gradient-echo sequence (TR/TE 150/1.07, 2.14, 3.21, 4.28, 5.35, 6.42, 7.49, 8.56, 9.63, 10.7, 11.77, 12.84, 13.91, 14.98, 16.05, 17.12, 18.19, 19.26, 20.33, 21.4&#xA0;ms; flip angle 35&#xB0;). <bold>a</bold> Second echo shows pixel annulation (<italic>arrows</italic>) due to out-of-phase phenomena, at the interfaces of abdominal organs and muscles with fat. <bold>b</bold> Fourth echo: no pixel annulation is observed because water and fat protons are in phase (courtesy of Dr. M. Douskou)</p></caption><graphic position="anchor" xlink:href="247_2007_567_Fig1_HTML" id="MO1"/></fig></p>
        </sec>
        <sec id="Sec11">
          <title>T2, T2* and hybrid methods</title>
          <p>There is no general consensus on which relaxometry method (spin-echo or gradient-echo) or index (R2, R2*, R2&#x2032;) is best for tissue iron quantification. Theoretically, R2* and R2&#x2032; are more sensitive than R2 to iron-induced field inhomogeneities. Gradient-echo sequences evaluating R2* are preferred for cardiac relaxometry, because of their short acquisition time, but gradient-echo sequences are more prone to artefacts and R2* is more dependent on factors unrelated to iron, such as susceptibility artefacts from the lungs and the blood oxygenation level-dependent (BOLD) effect [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]. According to the BOLD effect, the T2* decreases as the concentration of intracapillary deoxyhaemoglobin increases [<xref ref-type="bibr" rid="CR74">74</xref>]. A pronounced BOLD effect may be observed in early diastole and results in signal loss [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR76">76</xref>]. Data collection during mid-systole helps to overcome BOLD effect interference with accurate T2* measurements of the myocardium. In liver and pituitary studies both T2 and T2* have been assessed. T2* is more sensitive to low iron content, but studies in the liver show that these methods suffer from inaccuracies at high iron concentrations [<xref ref-type="bibr" rid="CR77">77</xref>]. Furthermore, in high fields susceptibility artefacts from the sphenoid sinus are more pronounced with gradient-echo sequences and may lead to inaccurate measurements of pituitary siderosis [<xref ref-type="bibr" rid="CR43">43</xref>].</p>
        </sec>
      </sec>
    </sec>
    <sec id="Sec12">
      <title>MRI studies of individual iron overloaded organs</title>
      <p>The degree of siderosis, the crystalline structure of ferritin, the rate of iron elimination under chelation therapy and the degree of ferrioxamine formation are all organ-specific [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. All these parameters may be responsible for differences in the T2 relaxation enhancement induced in the various organs. Individual organs should be considered separately, and the effect of age on iron overload should be taken into account. Higher survival probabilities have been reported in patients with thalassaemia born in the last 30&#xA0;years [<xref ref-type="bibr" rid="CR79">79</xref>]. Patient compliance with treatment regimens and effective chelation therapy are thought to be the main factors associated with improved survival [<xref ref-type="bibr" rid="CR79">79</xref>]. The combination of DFO, deferiprone and the new oral chelators is considered very promising, but will require effective monitoring by non-invasive methods [<xref ref-type="bibr" rid="CR80">80</xref>]. An increasing number of studies have evaluated iron in the various affected organs by MRI [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR22">22</xref>&#x2013;<xref ref-type="bibr" rid="CR44">44</xref>]. Many of these studies have included paediatric patients, but very few have investigated children younger than 10&#xA0;years and none has included children younger than 5&#xA0;years [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR60">60</xref>&#x2013;<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR81">81</xref>&#x2013;<xref ref-type="bibr" rid="CR84">84</xref>]. In addition, very few studies have evaluated the effect of age on individual organ siderosis and only one has evaluated and compared MRI data from younger and older patients with thalassaemia [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR84">84</xref>]. Studies have tended to focus on specific organs.</p>
      <sec id="Sec13">
        <title>Liver</title>
        <p>For the MRI evaluation of liver siderosis both SIR and relaxometry techniques have been used (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>) [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR85">85</xref>]. R2 of the liver demonstrates a significant positive correlation with serum ferritin and LIC determined from liver biopsy material [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR68">68</xref>]. Comparative evaluation of hepatic R2 and R2* in iron-overloaded patients demonstrates that both parameters correlate closely with LIC [<xref ref-type="bibr" rid="CR85">85</xref>]. The relationship of SIR with LIC and serum ferritin varies among studies [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. In most studies R2 and SIR show a better correlation with LIC than with serum ferritin [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR85">85</xref>]. This can be explained in part because the HCV-positive thalassaemia patients in the studies had higher serum ferritin levels than those who were HCV-negative [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR86">86</xref>]. Liver R2 shows no association with the hepatic inflammation histological activity index or the type of hepatitis (chronic persistent or chronic active), but is affected by hepatic fibrosis [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR77">77</xref>].
<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>A 17-year-old male with &#x3B2;-thalassaemia major. Axial scan, fourth echo of a multiecho spin-echo sequence (TR/TE: 2000/20, 40, 60, 80, 100, 120, 140, 160&#xA0;ms), shows low-signal intensity in the liver, bone marrow of the spinal body and the pancreas suggesting iron overload</p></caption><graphic position="anchor" xlink:href="247_2007_567_Fig2_HTML" id="MO2"/></fig></p>
        <p>In iron overload states, over 70% of body iron is found in the liver and LIC has been considered to be the best marker of total body iron burden [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Based on the good correlation between hepatic R2 or SIR and LIC a number of recent studies have tested the relationship between siderosis of the liver and other organs [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR58">58</xref>&#x2013;<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR87">87</xref>]. No correlation has been found between liver and pituitary siderosis [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. With regard to the heart, a correlation with liver siderosis has been found only in cases of heavy myocardial iron deposition [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. This lack of correlation can probably be explained by differences in transferrin receptor concentration, iron kinetics, the crystalline structure of ferritin and the degree of organ inflammation or fibrosis [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR88">88</xref>&#x2013;<xref ref-type="bibr" rid="CR92">92</xref>]. Furthermore, under chelation therapy with DFO intracellular paramagnetic ferrioxamine is formed, which exits slowly from cells unless there is an active excretion pathway as is present in the hepatocytes [<xref ref-type="bibr" rid="CR88">88</xref>].</p>
        <p>Young patients with thalassaemia studied longitudinally have shown absence of substantial improvement in the MR parameters of liver siderosis under different chelation therapy regimens [<xref ref-type="bibr" rid="CR82">82</xref>]. This may be explained by the fact that liver siderosis progresses very fast in thalassaemia patients, and iron overload develops after only 2&#xA0;years of transfusion therapy [<xref ref-type="bibr" rid="CR93">93</xref>]. Therapy with the most widely used chelating agent is started at the age of about 3&#xA0;years, and until growth is completed DFO should not exceed a dose of 40&#xA0;mg/kg per day [<xref ref-type="bibr" rid="CR7">7</xref>]. An early start to monitoring the progress of tissue iron deposition with MRI might be useful in deciding whether to begin chelation therapy at a younger age and when to introduce new chelating agents.</p>
      </sec>
      <sec id="Sec14">
        <title>Heart</title>
        <p>Cardiac failure is the leading cause of death from iron overload in patients with thalassaemia [<xref ref-type="bibr" rid="CR94">94</xref>, <xref ref-type="bibr" rid="CR95">95</xref>]. Thalassaemia patients on a regimen of regular blood transfusions who are not receiving chelation therapy, develop heart enlargement by the age of 10&#xA0;years and heart failure by the age of 16&#xA0;years [<xref ref-type="bibr" rid="CR22">22</xref>]. Cardiomyopathy secondary to iron overload is potentially reversible with vigorous chelation therapy [<xref ref-type="bibr" rid="CR7">7</xref>]. Myocardial iron has been evaluated by MRI using SIR and relaxometry techniques (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>) [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR96">96</xref>&#x2013;<xref ref-type="bibr" rid="CR98">98</xref>]. In the prechelation era, post-mortem examination of patients with thalassaemia showed a close correlation between cardiac and hepatic iron concentrations. MRI studies have demonstrated discordant results regarding the relationship of myocardial iron with hepatic iron and serum ferritin [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR97">97</xref>]. Differences in iron kinetics and variations in chelation schemes may be responsible for the lack of correlation of the MRI-determined myocardial iron with that of the liver [<xref ref-type="bibr" rid="CR88">88</xref>]. More active elimination of iron from the hepatocytes than from the myocytes may play a role in the absence of correlation in patients receiving chelation therapy [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR68">68</xref>].
<fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>A 16-year-old male with &#x3B2;-thalassaemia major. <bold>a</bold> T2 map of the short axis of the heart shows low values of the left ventricle (<italic>arrow</italic>) and the septum (<italic>arrowhead</italic>). <bold>b</bold> R2* (=1/T2*) map of the short axis of the heart shows high signal of the septum (<italic>asterisk</italic>). Note the reduction of motion artefacts and better delineation of the heart boundary in the R2* image (courtesy of Dr. M. Douskou)</p></caption><graphic position="anchor" xlink:href="247_2007_567_Fig3_HTML" id="MO3"/></fig></p>
        <p>Another important issue is whether myocardial iron evaluated by MRI could predict which patient will develop cardiac failure and arrhythmia. Thalassaemia patients with significantly reduced left ventricular ejection fraction (LVEF) have myocardial T2* values about 20&#xA0;ms [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR68">68</xref>], although most patients with T2* values less than 20&#xA0;ms have normal LVEF [<xref ref-type="bibr" rid="CR68">68</xref>]. Furthermore, the relationship between myocardial R2 and LVEF is either non-existent or weak [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR38">38</xref>&#x2013;<xref ref-type="bibr" rid="CR40">40</xref>]. Differences in cardiac functional indices among patients with similar MRI measurement of iron might also be explained by genetic factors that predispose to the more rapid development of cardiac failure when a critical level of myocardial siderosis is reached [<xref ref-type="bibr" rid="CR99">99</xref>, <xref ref-type="bibr" rid="CR100">100</xref>].</p>
        <p>Heterogeneous iron distribution in the myocardium has been demonstrated in histological studies, and this would suggest the necessity for global MRI estimation of myocardial iron [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR101">101</xref>]. Pepe et al. [<xref ref-type="bibr" rid="CR42">42</xref>], using T2* multiecho cardiac MRI, demonstrated that global T2* shows a close correlation with midseptal T2*, suggesting that the latter may be used for a quick assessment of myocardial siderosis.</p>
        <p>MR studies have shown that cardiac siderosis increases with age, but that siderosis progresses more slowly in the heart than in the liver [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR82">82</xref>]. Systematic MRI studies in children are necessary in order to evaluate the age at the start of cardiac iron overload.</p>
      </sec>
      <sec id="Sec15">
        <title>Pituitary gland and brain</title>
        <p>Increased iron deposition in the anterior pituitary gland is the cause of hypogonadotropic hypogonadism and growth hormone deficiency [<xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR103">103</xref>]. Iron accumulates in all five cell types of the adenohypophysis, but preferentially in the gonadotropin-secreting cells [<xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR103">103</xref>]. Gonadotropin cell death due to iron toxicity is probably the cause of the decreased pituitary gland height observed in thalassaemia patients with hypogonadotropic hypogonadism (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>) [<xref ref-type="bibr" rid="CR104">104</xref>]. MRI has been used to evaluate pituitary siderosis with SIR and relaxometry techniques [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR105">105</xref>]. SIR and R2 findings show significant correlation with serum ferritin [<xref ref-type="bibr" rid="CR83">83</xref>]. The very few studies evaluating simultaneously the pituitary and other solid organs have demonstrated no correlation between their MRI parameters of siderosis [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR81">81</xref>]. Pituitary siderosis appears to increase with age, but MR data are lacking for children under the age of 7&#xA0;years [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR81">81</xref>] [<xref ref-type="bibr" rid="CR84">84</xref>].
<fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>The pituitary. <bold>a</bold> A 12-year-old male with &#x3B2;-thalassaemia major. Midsagittal T1-weighted (TR/TE 500/20&#xA0;ms) scan shows low-signal intensity of the anterior pituitary lobe (<italic>arrow</italic>) and the bone marrow (<italic>asterisks</italic>) suggesting iron overload. The pituitary gland is small measuring 3.5&#xA0;mm (normal for age 5.3&#xB1;0.8&#xA0;mm) [<xref ref-type="bibr" rid="CR112">112</xref>]. This patient developed hypogonadotropic hypogonadism. <bold>b</bold> An 11-year-old male with &#x3B2;-thalassaemia major. Mid-sagittal T1-weighted (TR/TE 500/20&#xA0;ms) scan shows normal signal intensity of the anterior pituitary lobe (<italic>arrow</italic>) along with normal pituitary gland height (6&#xA0;mm). The bone marrow (<italic>asterisk</italic>) shows low-signal intensity suggesting iron overload</p></caption><graphic position="anchor" xlink:href="247_2007_567_Fig4_HTML" id="MO4"/></fig></p>
        <p>The single study assessing iron in the brain of thalassaemia patients by MRI [<xref ref-type="bibr" rid="CR106">106</xref>] showed significantly higher R2 values in the cortex, the putamen and the caudate nucleus in patients than in controls. A lack of correlation between R2 and serum ferritin was found, possibly because serum ferritin, which does not cross the blood&#x2013;brain barrier, is not a good marker of brain siderosis [<xref ref-type="bibr" rid="CR106">106</xref>].</p>
      </sec>
      <sec id="Sec16">
        <title>Pancreas</title>
        <p>Iron overload leads to impairment of the endocrine and exocrine functions of the pancreas [<xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR108">108</xref>]. Pancreatic siderosis has been evaluated in thalassaemia patients using SIR techniques and relaxometry techniques [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR109">109</xref>]. Midiri et al. [<xref ref-type="bibr" rid="CR109">109</xref>], using fat as the reference tissue, found a significant negative correlation of SIR with serum ferritin and trypsin. Papakonstantinou et al. [<xref ref-type="bibr" rid="CR61">61</xref>], using muscle as the reference tissue, found no relationship of the pancreatic SIR with the hepatic SIR or serum ferritin. The findings of Argyropoulou et al. [<xref ref-type="bibr" rid="CR84">84</xref>], using T2 relaxometry techniques, were similar. In addition, relaxometry techniques demonstrated that the T2 relaxation time of the pancreas of patients with thalassaemia is significantly lower in children than in adults [<xref ref-type="bibr" rid="CR84">84</xref>]. Fatty degeneration of the pancreas in adult patients may explain these differences (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>).
<fig id="Fig5"><label>Fig.&#xA0;5</label><caption><p>Siderosis of the spleen, pancreas and adrenals. <bold>a</bold> A 14-year-old male with &#x3B2;-thalassaemia major. Axial scan, fourth echo of a multiecho sequence (TR/TE 2,000/20, 40, 60, 80, 100, 120, 140, 160&#xA0;ms) shows low-signal intensity of the liver, pancreas (<italic>arrow</italic>) and spleen suggesting increased iron deposition. <bold>b</bold> A 27-year-old-male with &#x3B2;-thalassaemia major and diabetes. Axial T2-W (TR/TE 1,800/80&#xA0;ms) scan shows low-signal intensity of the liver and adrenals suggesting siderosis. High signal intensity of the pancreas (<italic>arrow</italic>) suggests tissue damage and fatty degeneration</p></caption><graphic position="anchor" xlink:href="247_2007_567_Fig5_HTML" id="MO5"/></fig></p>
      </sec>
      <sec id="Sec17">
        <title>Adrenals</title>
        <p>Abnormalities in adrenal function have been reported in patients with thalassaemia [<xref ref-type="bibr" rid="CR103">103</xref>]. There is only one study evaluating adrenals for iron overload with MRI (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>), which showed a significant correlation between adrenal and liver siderosis [<xref ref-type="bibr" rid="CR87">87</xref>].</p>
      </sec>
      <sec id="Sec18">
        <title>Spleen, lymph nodes and bone marrow</title>
        <p>In spite of the fact that the spleen, lymph nodes and bone marrow, which all contain reticuloendothelial cells, are among the first organs to be affected by iron overload [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR13">13</xref>], there have been very few studies evaluating their iron overload in thalassaemia by MRI, and these used mainly SIR techniques [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR84">84</xref>]. SIR of the spleen shows a significant correlation with serum ferritin but not with SIR of the liver (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>) [<xref ref-type="bibr" rid="CR62">62</xref>]. The absence of correlation between liver and spleen siderosis could be explained by differences in iron kinetics, by differences in the cluster size of iron proteins, by haemochromatosis gene mutations in &#x3B2;-thalassaemia major carriers, and by the presence of extramedullary haemopoietic tissue in the spleen [<xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR110">110</xref>, <xref ref-type="bibr" rid="CR111">111</xref>]. Intraabdominal lymph nodes in &#x3B2;-thalassaemia have been related to chronic hepatitis C [<xref ref-type="bibr" rid="CR60">60</xref>]. Lymph node siderosis correlates with liver, but not with spleen siderosis [<xref ref-type="bibr" rid="CR60">60</xref>].</p>
        <p>In the few studies that have been reported, SIR and relaxometry methods have shown discordant results for MR parameters of bone marrow siderosis and serum ferritin [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR84">84</xref>]. Normal bone marrow signal associated with liver siderosis has been reported in a few patients with thalassaemia and this may be due to differences in genotype or differences in chelation therapy regimens [<xref ref-type="bibr" rid="CR59">59</xref>].</p>
      </sec>
    </sec>
    <sec id="Sec19" sec-type="conclusion">
      <title>Conclusion</title>
      <p>It is evident that MR relaxometry has the potential to become the method of choice for non-invasive, safe and accurate assessment of iron load. Further theoretical research, along with studies monitoring wider age groups of patients are needed before a generally accepted protocol can be established. Until then, extreme caution is needed in its clinical application and interpretation. Experimental artefacts, non-optimized protocols, poor data analysis and unawareness of the inherent limitations of current methodologies in assessing a heavy body iron burden can result in misleading diagnosis and inappropriate management of thalassaemia patients with iron overload. Future experimental developments in relaxometry based on a better theoretical understanding of the contribution of the iron-containing proteins to the MR signal are expected to further strengthen its clinical role in the monitoring of patients with &#x3B2;-thalassaemia major.</p>
    </sec>
  </body>
  <back>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rund</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rachmilewitz</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Beta-thalassemia</article-title>
          <source>N Engl J Med</source>
          <year>2005</year>
          <volume>353</volume>
          <fpage>1135</fpage>
          <lpage>1146</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rund D, Rachmilewitz E (2005) Beta-thalassemia. N Engl J Med 353:1135&#x2013;1146 <pub-id pub-id-type="pmid">16162884</pub-id></citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Forget</surname>
              <given-names>BG</given-names>
            </name>
          </person-group>
          <article-title>The pathophysiology and molecular genetics of beta thalassemia</article-title>
          <source>Mt Sinai J Med</source>
          <year>1993</year>
          <volume>60</volume>
          <fpage>95</fpage>
          <lpage>103</lpage>
        </citation>
        <citation citation-type="display-unstructured">Forget BG (1993) The pathophysiology and molecular genetics of beta thalassemia. Mt Sinai J Med 60:95&#x2013;103 <pub-id pub-id-type="pmid">8469250</pub-id></citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pootrakul</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sirankapracha</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hemsorach</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in Thai patients with thalassemia</article-title>
          <source>Blood</source>
          <year>2000</year>
          <volume>96</volume>
          <fpage>2606</fpage>
          <lpage>2612</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pootrakul P, Sirankapracha P, Hemsorach S et al (2000) A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in Thai patients with thalassemia. Blood 96:2606&#x2013;2612 <pub-id pub-id-type="pmid">11001918</pub-id></citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hentze</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Muckenthaler</surname>
              <given-names>MU</given-names>
            </name>
            <name>
              <surname>Andrews</surname>
              <given-names>NC</given-names>
            </name>
          </person-group>
          <article-title>Balancing acts: molecular control of mammalian iron metabolism</article-title>
          <source>Cell</source>
          <year>2004</year>
          <volume>117</volume>
          <fpage>285</fpage>
          <lpage>297</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hentze MW, Muckenthaler MU, Andrews NC (2004) Balancing acts: molecular control of mammalian iron metabolism. Cell 117:285&#x2013;297 <pub-id pub-id-type="pmid">15109490</pub-id></citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gossuin</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Gillis</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Relaxation induced by ferritin: a better understanding for an improved MRI iron quantification</article-title>
          <source>NMR Biomed</source>
          <year>2004</year>
          <volume>17</volume>
          <fpage>427</fpage>
          <lpage>432</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gossuin Y, Muller RN, Gillis P (2004) Relaxation induced by ferritin: a better understanding for an improved MRI iron quantification. NMR Biomed 17:427&#x2013;432 <pub-id pub-id-type="pmid">15526352</pub-id></citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brittenham</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>Iron balance in the red blood cell donor</article-title>
          <source>Dev Biol (Basel)</source>
          <year>2005</year>
          <volume>120</volume>
          <fpage>77</fpage>
          <lpage>82</lpage>
        </citation>
        <citation citation-type="display-unstructured">Brittenham GM (2005) Iron balance in the red blood cell donor. Dev Biol (Basel) 120:77&#x2013;82 <pub-id pub-id-type="pmid">16050159</pub-id></citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Porter</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>BA</given-names>
            </name>
          </person-group>
          <article-title>Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia</article-title>
          <source>Best Pract Res Clin Haematol</source>
          <year>2002</year>
          <volume>15</volume>
          <fpage>329</fpage>
          <lpage>368</lpage>
        </citation>
        <citation citation-type="display-unstructured">Porter JB, Davis BA (2002) Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. Best Pract Res Clin Haematol 15:329&#x2013;368 <pub-id pub-id-type="pmid">12401311</pub-id></citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cunningham</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Nathan</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
          <article-title>New developments in iron chelators</article-title>
          <source>Curr Opin Hematol</source>
          <year>2005</year>
          <volume>12</volume>
          <fpage>129</fpage>
          <lpage>134</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cunningham MJ, Nathan DG (2005) New developments in iron chelators. Curr Opin Hematol 12:129&#x2013;134 <pub-id pub-id-type="pmid">15725903</pub-id></citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hershko</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Link</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Konijn</surname>
              <given-names>AM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Objectives and mechanism of iron chelation therapy</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>2005</year>
          <volume>1054</volume>
          <fpage>124</fpage>
          <lpage>135</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hershko C, Link G, Konijn AM et al (2005) Objectives and mechanism of iron chelation therapy. Ann N Y Acad Sci 1054:124&#x2013;135 <pub-id pub-id-type="pmid">16339658</pub-id></citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chaston</surname>
              <given-names>TB</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>Iron chelators for the treatment of iron overload disease: relationship between structure, redox activity, and toxicity</article-title>
          <source>Am J Hematol</source>
          <year>2003</year>
          <volume>73</volume>
          <fpage>200</fpage>
          <lpage>210</lpage>
        </citation>
        <citation citation-type="display-unstructured">Chaston TB, Richardson DR (2003) Iron chelators for the treatment of iron overload disease: relationship between structure, redox activity, and toxicity. Am J Hematol 73:200&#x2013;210 <pub-id pub-id-type="pmid">12827659</pub-id></citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Torti</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Torti</surname>
              <given-names>SV</given-names>
            </name>
          </person-group>
          <article-title>Regulation of ferritin genes and protein</article-title>
          <source>Blood</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>3505</fpage>
          <lpage>3516</lpage>
        </citation>
        <citation citation-type="display-unstructured">Torti FM, Torti SV (2002) Regulation of ferritin genes and protein. Blood 99:3505&#x2013;3516 <pub-id pub-id-type="pmid">11986201</pub-id></citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rothman</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Serroni</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Farber</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from ferritin, that is involved in oxidative cell injury</article-title>
          <source>Mol Pharmacol</source>
          <year>1992</year>
          <volume>42</volume>
          <fpage>703</fpage>
          <lpage>710</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rothman RJ, Serroni A, Farber JL (1992) Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from ferritin, that is involved in oxidative cell injury. Mol Pharmacol 42:703&#x2013;710 <pub-id pub-id-type="pmid">1435746</pub-id></citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gabutti</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Piga</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sacchetti</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Quality of life and life expectancy in thalassemic patients with complications</article-title>
          <source>Prog Clin Biol Res</source>
          <year>1989</year>
          <volume>309</volume>
          <fpage>35</fpage>
          <lpage>41</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gabutti V, Piga A, Sacchetti L et al (1989) Quality of life and life expectancy in thalassemic patients with complications. Prog Clin Biol Res 309:35&#x2013;41 <pub-id pub-id-type="pmid">2780748</pub-id></citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saito</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nishisato</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Grasso</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Interaction of transferrin with iron-loaded rat peritoneal macrophages</article-title>
          <source>Br J Haematol</source>
          <year>1986</year>
          <volume>62</volume>
          <fpage>275</fpage>
          <lpage>286</lpage>
        </citation>
        <citation citation-type="display-unstructured">Saito K, Nishisato T, Grasso JA et al (1986) Interaction of transferrin with iron-loaded rat peritoneal macrophages. Br J Haematol 62:275&#x2013;286 <pub-id pub-id-type="pmid">3947549</pub-id></citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Porter</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Rafique</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Srichairatanakool</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recent insights into interactions of deferoxamine with cellular and plasma iron pools: Implications for clinical use</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>2005</year>
          <volume>1054</volume>
          <fpage>155</fpage>
          <lpage>168</lpage>
        </citation>
        <citation citation-type="display-unstructured">Porter JB, Rafique R, Srichairatanakool S et al (2005) Recent insights into interactions of deferoxamine with cellular and plasma iron pools: Implications for clinical use. Ann N Y Acad Sci 1054:155&#x2013;168 <pub-id pub-id-type="pmid">16339661</pub-id></citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shalev</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Repka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Goldfarb</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo</article-title>
          <source>Blood</source>
          <year>1995</year>
          <volume>86</volume>
          <fpage>2008</fpage>
          <lpage>2013</lpage>
        </citation>
        <citation citation-type="display-unstructured">Shalev O, Repka T, Goldfarb A et al (1995) Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo. Blood 86:2008&#x2013;2013 <pub-id pub-id-type="pmid">7655028</pub-id></citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mazza</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Giua</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Marco</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver</article-title>
          <source>Haematologica</source>
          <year>1995</year>
          <volume>80</volume>
          <fpage>398</fpage>
          <lpage>404</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mazza P, Giua R, De Marco S et al (1995) Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver. Haematologica 80:398&#x2013;404 <pub-id pub-id-type="pmid">8566878</pub-id></citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Papakonstantinou</surname>
              <given-names>OG</given-names>
            </name>
            <name>
              <surname>Maris</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Kostaridou</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Assessment of liver iron overload by T2-quantitative magnetic resonance imaging: correlation of T2-QMRI measurements with serum ferritin concentration and histologic grading of siderosis</article-title>
          <source>Magn Reson Imaging</source>
          <year>1995</year>
          <volume>13</volume>
          <fpage>967</fpage>
          <lpage>977</lpage>
        </citation>
        <citation citation-type="display-unstructured">Papakonstantinou OG, Maris TG, Kostaridou V et al (1995) Assessment of liver iron overload by T2-quantitative magnetic resonance imaging: correlation of T2-QMRI measurements with serum ferritin concentration and histologic grading of siderosis. Magn Reson Imaging 13:967&#x2013;977 <pub-id pub-id-type="pmid">8583875</pub-id></citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gandon</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Olivie</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Guyader</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Non-invasive assessment of hepatic iron stores by MRI</article-title>
          <source>Lancet</source>
          <year>2004</year>
          <volume>363</volume>
          <fpage>357</fpage>
          <lpage>362</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gandon Y, Olivie D, Guyader D et al (2004) Non-invasive assessment of hepatic iron stores by MRI. Lancet 363:357&#x2013;362 <pub-id pub-id-type="pmid">15070565</pub-id></citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Locasciulli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Monguzzi</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Tornotti</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hepatitis C virus infection and liver disease in children with thalassemia</article-title>
          <source>Bone Marrow Transplant</source>
          <year>1993</year>
          <volume>12</volume>
          <issue>Suppl 1</issue>
          <fpage>18</fpage>
          <lpage>20</lpage>
        </citation>
        <citation citation-type="display-unstructured">Locasciulli A, Monguzzi W, Tornotti G et al (1993) Hepatitis C virus infection and liver disease in children with thalassemia. Bone Marrow Transplant 12 [Suppl 1]:18&#x2013;20 <pub-id pub-id-type="pmid">7690633</pub-id></citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tong</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>el-Farra</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Reikes</surname>
              <given-names>AR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical outcomes after transfusion-associated hepatitis C</article-title>
          <source>N Engl J Med</source>
          <year>1995</year>
          <volume>332</volume>
          <fpage>1463</fpage>
          <lpage>1466</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tong MJ, el-Farra NS, Reikes AR et al (1995) Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463&#x2013;1466 <pub-id pub-id-type="pmid">7739682</pub-id></citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pennell</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>T2* magnetic resonance and myocardial iron in thalassemia</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>2005</year>
          <volume>1054</volume>
          <fpage>373</fpage>
          <lpage>378</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pennell DJ (2005) T2* magnetic resonance and myocardial iron in thalassemia. Ann N Y Acad Sci 1054:373&#x2013;378 <pub-id pub-id-type="pmid">16339685</pub-id></citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaltwasser</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Gottschalk</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schalk</surname>
              <given-names>KP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Non-invasive quantitation of liver iron-overload by magnetic resonance imaging</article-title>
          <source>Br J Haematol</source>
          <year>1990</year>
          <volume>74</volume>
          <fpage>360</fpage>
          <lpage>363</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kaltwasser JP, Gottschalk R, Schalk KP et al (1990) Non-invasive quantitation of liver iron-overload by magnetic resonance imaging. Br J Haematol 74:360&#x2013;363 <pub-id pub-id-type="pmid">2334643</pub-id></citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chezmar</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Malko</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hepatic iron overload: diagnosis and quantification by noninvasive imaging</article-title>
          <source>Gastrointest Radiol</source>
          <year>1990</year>
          <volume>15</volume>
          <fpage>27</fpage>
          <lpage>31</lpage>
        </citation>
        <citation citation-type="display-unstructured">Chezmar JL, Nelson RC, Malko JA et al (1990) Hepatic iron overload: diagnosis and quantification by noninvasive imaging. Gastrointest Radiol 15:27&#x2013;31 <pub-id pub-id-type="pmid">2298350</pub-id></citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonkovsky</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Slaker</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Bills</surname>
              <given-names>EB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease</article-title>
          <source>Gastroenterology</source>
          <year>1990</year>
          <volume>99</volume>
          <fpage>1079</fpage>
          <lpage>1091</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bonkovsky HL, Slaker DP, Bills EB et al (1990) Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease. Gastroenterology 99:1079&#x2013;1091 <pub-id pub-id-type="pmid">2394329</pub-id></citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guyader</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gandon</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Robert</surname>
              <given-names>JY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Magnetic resonance imaging and assessment of liver iron content in genetic hemochromatosis</article-title>
          <source>J Hepatol</source>
          <year>1992</year>
          <volume>15</volume>
          <fpage>304</fpage>
          <lpage>308</lpage>
        </citation>
        <citation citation-type="display-unstructured">Guyader D, Gandon Y, Robert JY et al (1992) Magnetic resonance imaging and assessment of liver iron content in genetic hemochromatosis. J Hepatol 15:304&#x2013;308 <pub-id pub-id-type="pmid">1447496</pub-id></citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ernst</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Sergent</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bonvarlet</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hepatic iron overload: diagnosis and quantification with MR imaging</article-title>
          <source>AJR</source>
          <year>1997</year>
          <volume>168</volume>
          <fpage>1205</fpage>
          <lpage>1208</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ernst O, Sergent G, Bonvarlet P et al (1997) Hepatic iron overload: diagnosis and quantification with MR imaging. AJR 168:1205&#x2013;1208 <pub-id pub-id-type="pmid">9129412</pub-id></citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christoforidis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Haritandi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tsitouridis</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients</article-title>
          <source>J Pediatr Hematol Oncol</source>
          <year>2006</year>
          <volume>28</volume>
          <fpage>311</fpage>
          <lpage>315</lpage>
        </citation>
        <citation citation-type="display-unstructured">Christoforidis A, Haritandi A, Tsitouridis I et al (2006) Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients. J Pediatr Hematol Oncol 28:311&#x2013;315 <pub-id pub-id-type="pmid">16772883</pub-id></citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hepatic iron deposition on magnetic resonance imaging: correlation with inflammatory activity</article-title>
          <source>J Comput Assist Tomogr</source>
          <year>2002</year>
          <volume>26</volume>
          <fpage>988</fpage>
          <lpage>993</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kim MJ, Mitchell DG, Ito K et al (2002) Hepatic iron deposition on magnetic resonance imaging: correlation with inflammatory activity. J Comput Assist Tomogr 26:988&#x2013;993 <pub-id pub-id-type="pmid">12488748</pub-id></citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gandon</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Guyader</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Heautot</surname>
              <given-names>JF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging</article-title>
          <source>Radiology</source>
          <year>1994</year>
          <volume>193</volume>
          <fpage>533</fpage>
          <lpage>538</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gandon Y, Guyader D, Heautot JF et al (1994) Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology 193:533&#x2013;538 <pub-id pub-id-type="pmid">7972774</pub-id></citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rocchi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Cassanelli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Borghi</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Magnetic resonance imaging and different levels of iron overload in chronic liver disease</article-title>
          <source>Hepatology</source>
          <year>1993</year>
          <volume>17</volume>
          <fpage>997</fpage>
          <lpage>1002</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rocchi E, Cassanelli M, Borghi A et al (1993) Magnetic resonance imaging and different levels of iron overload in chronic liver disease. Hepatology 17:997&#x2013;1002 <pub-id pub-id-type="pmid">8514272</pub-id></citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gomori</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Horev</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tamary</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hepatic iron overload: quantitative MR imaging</article-title>
          <source>Radiology</source>
          <year>1991</year>
          <volume>179</volume>
          <fpage>367</fpage>
          <lpage>369</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gomori JM, Horev G, Tamary H et al (1991) Hepatic iron overload: quantitative MR imaging. Radiology 179:367&#x2013;369 <pub-id pub-id-type="pmid">2014276</pub-id></citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bartzokis</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Aravagiri</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Oldendorf</surname>
              <given-names>WH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores</article-title>
          <source>Magn Reson Med</source>
          <year>1993</year>
          <volume>29</volume>
          <fpage>459</fpage>
          <lpage>464</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bartzokis G, Aravagiri M, Oldendorf WH et al (1993) Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn Reson Med 29:459&#x2013;464 <pub-id pub-id-type="pmid">8464361</pub-id></citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gelman</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gorell</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Barker</surname>
              <given-names>PB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content</article-title>
          <source>Radiology</source>
          <year>1999</year>
          <volume>210</volume>
          <fpage>759</fpage>
          <lpage>767</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gelman N, Gorell JM, Barker PB et al (1999) MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 210:759&#x2013;767 <pub-id pub-id-type="pmid">10207479</pub-id></citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ghugre</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Enriquez</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Coates</surname>
              <given-names>TD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Improved R2* measurements in myocardial iron overload</article-title>
          <source>J Magn Reson Imaging</source>
          <year>2006</year>
          <volume>23</volume>
          <fpage>9</fpage>
          <lpage>16</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ghugre NR, Enriquez CM, Coates TD et al (2006) Improved R2* measurements in myocardial iron overload. J Magn Reson Imaging 23:9&#x2013;16 <pub-id pub-id-type="pmid">16329085</pub-id></citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mavrogeni</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Markussis</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Kaklamanis</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major</article-title>
          <source>Eur J Haematol</source>
          <year>2005</year>
          <volume>75</volume>
          <fpage>241</fpage>
          <lpage>247</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mavrogeni SI, Markussis V, Kaklamanis L et al (2005) A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol 75:241&#x2013;247 <pub-id pub-id-type="pmid">16104881</pub-id></citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aessopos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Giakoumis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fragodimitri</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Correlation of echocardiography parameters with cardiac magnetic resonance imaging in transfusion-dependent thalassaemia major</article-title>
          <source>Eur J Haematol</source>
          <year>2007</year>
          <volume>78</volume>
          <fpage>58</fpage>
          <lpage>65</lpage>
        </citation>
        <citation citation-type="display-unstructured">Aessopos A, Giakoumis A, Fragodimitri C et al (2007) Correlation of echocardiography parameters with cardiac magnetic resonance imaging in transfusion-dependent thalassaemia major. Eur J Haematol 78:58&#x2013;65 <pub-id pub-id-type="pmid">17038018</pub-id></citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pennell</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>MRI and iron-overload cardiomyopathy in thalassaemia</article-title>
          <source>Circulation</source>
          <year>2006</year>
          <volume>113</volume>
          <fpage>f43</fpage>
          <lpage>44</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pennell D (2006) MRI and iron-overload cardiomyopathy in thalassaemia. Circulation 113:f43&#x2013;44 <pub-id pub-id-type="pmid">16552847</pub-id></citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alexopoulou</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Stripeli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Baras</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients</article-title>
          <source>J Magn Reson Imaging</source>
          <year>2006</year>
          <volume>23</volume>
          <fpage>163</fpage>
          <lpage>170</lpage>
        </citation>
        <citation citation-type="display-unstructured">Alexopoulou E, Stripeli F, Baras P et al (2006) R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients. J Magn Reson Imaging 23:163&#x2013;170 <pub-id pub-id-type="pmid">16374880</pub-id></citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Voskaridou</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Douskou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Terpos</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease</article-title>
          <source>Br J Haematol</source>
          <year>2004</year>
          <volume>126</volume>
          <fpage>736</fpage>
          <lpage>742</lpage>
        </citation>
        <citation citation-type="display-unstructured">Voskaridou E, Douskou M, Terpos E et al (2004) Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br J Haematol 126:736&#x2013;742 <pub-id pub-id-type="pmid">15327528</pub-id></citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carneiro</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Fernandes</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Araujo</surname>
              <given-names>DB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Liver iron concentration evaluated by two magnetic methods: magnetic resonance imaging and magnetic susceptometry</article-title>
          <source>Magn Reson Med</source>
          <year>2005</year>
          <volume>54</volume>
          <fpage>122</fpage>
          <lpage>128</lpage>
        </citation>
        <citation citation-type="display-unstructured">Carneiro AA, Fernandes JP, de Araujo DB et al (2005) Liver iron concentration evaluated by two magnetic methods: magnetic resonance imaging and magnetic susceptometry. Magn Reson Med 54:122&#x2013;128 <pub-id pub-id-type="pmid">15968652</pub-id></citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pepe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Positano</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Santarelli</surname>
              <given-names>MF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload</article-title>
          <source>J Magn Reson Imaging</source>
          <year>2006</year>
          <volume>23</volume>
          <fpage>662</fpage>
          <lpage>668</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pepe A, Positano V, Santarelli MF et al (2006) Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload. J Magn Reson Imaging 23:662&#x2013;668 <pub-id pub-id-type="pmid">16568436</pub-id></citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Argyropoulou</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Metafratzi</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Kiortsis</surname>
              <given-names>DN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>T2 relaxation rate as an index of pituitary iron overload in patients with beta-thalassemia major</article-title>
          <source>AJR</source>
          <year>2000</year>
          <volume>175</volume>
          <fpage>1567</fpage>
          <lpage>1569</lpage>
        </citation>
        <citation citation-type="display-unstructured">Argyropoulou MI, Metafratzi Z, Kiortsis DN et al (2000) T2 relaxation rate as an index of pituitary iron overload in patients with beta-thalassemia major. AJR 175:1567&#x2013;1569 <pub-id pub-id-type="pmid">11090376</pub-id></citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>St Pierre</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Chua-anusorn</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance</article-title>
          <source>Blood</source>
          <year>2005</year>
          <volume>105</volume>
          <fpage>855</fpage>
          <lpage>861</lpage>
        </citation>
        <citation citation-type="display-unstructured">St Pierre TG, Clark PR, Chua-anusorn W et al (2005) Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 105:855&#x2013;861 <pub-id pub-id-type="pmid">15256427</pub-id></citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brittenham</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Badman</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
          <article-title>Noninvasive measurement of iron: report of an NIDDK workshop</article-title>
          <source>Blood</source>
          <year>2003</year>
          <volume>101</volume>
          <fpage>15</fpage>
          <lpage>19</lpage>
        </citation>
        <citation citation-type="display-unstructured">Brittenham GM, Badman DG (2003) Noninvasive measurement of iron: report of an NIDDK workshop. Blood 101:15&#x2013;19 <pub-id pub-id-type="pmid">12393526</pub-id></citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>ZJ</given-names>
            </name>
            <name>
              <surname>Haselgrove</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>MB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evaluation of iron overload by single voxel MRS measurement of liver T2</article-title>
          <source>J Magn Reson Imaging</source>
          <year>2002</year>
          <volume>15</volume>
          <fpage>395</fpage>
          <lpage>400</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wang ZJ, Haselgrove JC, Martin MB et al (2002) Evaluation of iron overload by single voxel MRS measurement of liver T2. J Magn Reson Imaging 15:395&#x2013;400 <pub-id pub-id-type="pmid">11948828</pub-id></citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vymazal</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Urgosik</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bulte</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Differentiation between hemosiderin- and ferritin-bound brain iron using nuclear magnetic resonance and magnetic resonance imaging</article-title>
          <source>Cell Mol Biol (Noisy-le-grand)</source>
          <year>2000</year>
          <volume>46</volume>
          <fpage>835</fpage>
          <lpage>842</lpage>
        </citation>
        <citation citation-type="display-unstructured">Vymazal J, Urgosik D, Bulte JW (2000) Differentiation between hemosiderin- and ferritin-bound brain iron using nuclear magnetic resonance and magnetic resonance imaging. Cell Mol Biol (Noisy-le-grand) 46:835&#x2013;842 <pub-id pub-id-type="pmid">10875444</pub-id></citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Halle</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Bellisent-Funel</surname>
              <given-names>M-C</given-names>
            </name>
          </person-group>
          <article-title>Water in biological systems: the NMR picture</article-title>
          <source>Hydration processes in biology</source>
          <year>1999</year>
          <publisher-loc>Amsterdam</publisher-loc>
          <publisher-name>IOS Press</publisher-name>
          <fpage>221</fpage>
          <lpage>222</lpage>
        </citation>
        <citation citation-type="display-unstructured">Halle B (1999) Water in biological systems: the NMR picture. In: Bellisent-Funel M-C (ed) Hydration processes in biology. IOS Press, Amsterdam, pp 221&#x2013;232 </citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tian</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evaluation of hydroxyethyl-starch-ferrioxamine as an intravascular MR contrast agent for assessment of myocardial perfusion</article-title>
          <source>Acta Radiol Suppl</source>
          <year>1997</year>
          <volume>412</volume>
          <fpage>85</fpage>
          <lpage>90</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tian G, Shen J, Su S et al (1997) Evaluation of hydroxyethyl-starch-ferrioxamine as an intravascular MR contrast agent for assessment of myocardial perfusion. Acta Radiol Suppl 412:85&#x2013;90 <pub-id pub-id-type="pmid">9240086</pub-id></citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bloembergen</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Proton relaxation time in paramagnetic solutions</article-title>
          <source>J Chem Phys</source>
          <year>1957</year>
          <volume>25</volume>
          <fpage>572</fpage>
          <lpage>573</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bloembergen N (1957) Proton relaxation time in paramagnetic solutions. J Chem Phys 25:572&#x2013;573 </citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gueron</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Nuclear relaxation in macromolecules by paramagnetic ions: a novel mechanism</article-title>
          <source>J Magn Reson</source>
          <year>1975</year>
          <volume>19</volume>
          <fpage>58</fpage>
          <lpage>66</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gueron M (1975) Nuclear relaxation in macromolecules by paramagnetic ions: a novel mechanism. J Magn Reson 19:58&#x2013;66 </citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gillis</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Roch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brooks</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Corrected equations for susceptibility-induced T2-shortening</article-title>
          <source>J Magn Reson</source>
          <year>1999</year>
          <volume>137</volume>
          <fpage>402</fpage>
          <lpage>407</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gillis P, Roch A, Brooks RA (1999) Corrected equations for susceptibility-induced T2-shortening. J Magn Reson 137:402&#x2013;407 <pub-id pub-id-type="pmid">10089175</pub-id></citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gillis</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Koenig</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Transverse relaxation of solvent protons induced by magnetized spheres: application to ferritin, erythrocytes, and magnetite</article-title>
          <source>Magn Reson Med</source>
          <year>1987</year>
          <volume>5</volume>
          <fpage>323</fpage>
          <lpage>345</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gillis P, Koenig SH (1987) Transverse relaxation of solvent protons induced by magnetized spheres: application to ferritin, erythrocytes, and magnetite. Magn Reson Med 5:323&#x2013;345 <pub-id pub-id-type="pmid">2824967</pub-id></citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gillis</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Moiny</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Brooks</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>On T(2)-shortening by strongly magnetized spheres: a partial refocusing model</article-title>
          <source>Magn Reson Med</source>
          <year>2002</year>
          <volume>47</volume>
          <fpage>257</fpage>
          <lpage>263</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gillis P, Moiny F, Brooks RA (2002) On T(2)-shortening by strongly magnetized spheres: a partial refocusing model. Magn Reson Med 47:257&#x2013;263 <pub-id pub-id-type="pmid">11810668</pub-id></citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gossuin</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Roch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>RN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Anomalous nuclear magnetic relaxation of aqueous solutions of ferritin: an unprecedented first-order mechanism</article-title>
          <source>Magn Reson Med</source>
          <year>2002</year>
          <volume>48</volume>
          <fpage>959</fpage>
          <lpage>964</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gossuin Y, Roch A, Muller RN et al (2002) Anomalous nuclear magnetic relaxation of aqueous solutions of ferritin: an unprecedented first-order mechanism. Magn Reson Med 48:959&#x2013;964 <pub-id pub-id-type="pmid">12465104</pub-id></citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Denisov</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Venu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Orientational disorder and entropy of water in protein cavities</article-title>
          <source>J Phys Chem B</source>
          <year>1997</year>
          <volume>101</volume>
          <fpage>9380</fpage>
          <lpage>9389</lpage>
        </citation>
        <citation citation-type="display-unstructured">Denisov V, Venu K, Peters J et al (1997) Orientational disorder and entropy of water in protein cavities. J Phys Chem B 101:9380&#x2013;9389 </citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gossuin</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Roch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bue</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nuclear magnetic relaxation dispersion of ferritin and ferritin-like magnetic particle solutions: a pH-effect study</article-title>
          <source>Magn Reson Med</source>
          <year>2001</year>
          <volume>46</volume>
          <fpage>476</fpage>
          <lpage>481</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gossuin Y, Roch A, Lo Bue F et al (2001) Nuclear magnetic relaxation dispersion of ferritin and ferritin-like magnetic particle solutions: a pH-effect study. Magn Reson Med 46:476&#x2013;481 <pub-id pub-id-type="pmid">11550238</pub-id></citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Argyropoulou</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Kiortsis</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Efremidis</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>MRI of the liver and the pituitary gland in patients with beta-thalassemia major: does hepatic siderosis predict pituitary iron deposition?</article-title>
          <source>Eur Radiol</source>
          <year>2003</year>
          <volume>13</volume>
          <fpage>12</fpage>
          <lpage>16</lpage>
        </citation>
        <citation citation-type="display-unstructured">Argyropoulou MI, Kiortsis DN, Efremidis SC (2003) MRI of the liver and the pituitary gland in patients with beta-thalassemia major: does hepatic siderosis predict pituitary iron deposition? Eur Radiol 13:12&#x2013;16 <pub-id pub-id-type="pmid">12541105</pub-id></citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drakonaki</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Maris</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Papadakis</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Bone marrow changes in beta-thalassemia major: quantitative MR imaging findings and correlation with iron stores</article-title>
          <source>Eur Radiol</source>
          <year>2007</year>
          <volume>17</volume>
          <fpage>2079</fpage>
          <lpage>2087</lpage>
        </citation>
        <citation citation-type="display-unstructured">Drakonaki EE, Maris TG, Papadakis A et al (2007) Bone marrow changes in beta-thalassemia major: quantitative MR imaging findings and correlation with iron stores. Eur Radiol 17:2079&#x2013;2087 <pub-id pub-id-type="pmid">17180327</pub-id></citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Papakonstantinou</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Maris</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Kostaridou</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Abdominal lymphadenopathy in beta-thalassemia: MRI features and correlation with liver iron overload and posttransfusion chronic hepatitis C</article-title>
          <source>AJR</source>
          <year>2005</year>
          <volume>185</volume>
          <fpage>219</fpage>
          <lpage>224</lpage>
        </citation>
        <citation citation-type="display-unstructured">Papakonstantinou O, Maris TG, Kostaridou S et al (2005) Abdominal lymphadenopathy in beta-thalassemia: MRI features and correlation with liver iron overload and posttransfusion chronic hepatitis C. AJR 185:219&#x2013;224 <pub-id pub-id-type="pmid">15972427</pub-id></citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Papakonstantinou</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Ladis</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Kostaridou</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The pancreas in beta-thalassemia major: MR imaging features and correlation with iron stores and glucose disturbances</article-title>
          <source>Eur Radiol</source>
          <year>2006</year>
          <volume>17</volume>
          <fpage>1535</fpage>
          <lpage>1543</lpage>
        </citation>
        <citation citation-type="display-unstructured">Papakonstantinou O, Ladis V, Kostaridou S et al (2006) The pancreas in beta-thalassemia major: MR imaging features and correlation with iron stores and glucose disturbances. Eur Radiol 17:1535&#x2013;1543 <pub-id pub-id-type="pmid">17149622</pub-id></citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <citation citation-type="other">Papakonstantinou O, Drakonaki EE, Maris T et al (2006) MR imaging of spleen in beta-thalassemia major. Abdom Imaging. DOI 10.1007/s00261-006-9138-4</citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>St Pierre</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Chua-Anusorn</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Measurement and mapping of liver iron concentrations using magnetic resonance imaging</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>2005</year>
          <volume>1054</volume>
          <fpage>379</fpage>
          <lpage>385</lpage>
        </citation>
        <citation citation-type="display-unstructured">St Pierre TG, Clark PR, Chua-Anusorn W (2005) Measurement and mapping of liver iron concentrations using magnetic resonance imaging. Ann N Y Acad Sci 1054:379&#x2013;385 <pub-id pub-id-type="pmid">16339686</pub-id></citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fenzi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bortolazzi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marzola</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Comparison between signal-to-noise ratio, liver-to-muscle ratio, and 1/T2 for the noninvasive assessment of liver iron content by MRI</article-title>
          <source>J Magn Reson Imaging</source>
          <year>2003</year>
          <volume>17</volume>
          <fpage>589</fpage>
          <lpage>592</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fenzi A, Bortolazzi M, Marzola P (2003) Comparison between signal-to-noise ratio, liver-to-muscle ratio, and 1/T2 for the noninvasive assessment of liver iron content by MRI. J Magn Reson Imaging 17:589&#x2013;592 <pub-id pub-id-type="pmid">12720269</pub-id></citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carr</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Purcell</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Effects of diffusion on free precession in nuclear magnetic resonance experiments</article-title>
          <source>Phys Rev</source>
          <year>1954</year>
          <volume>94</volume>
          <fpage>630</fpage>
          <lpage>638</lpage>
        </citation>
        <citation citation-type="display-unstructured">Carr HY, Purcell EM (1954) Effects of diffusion on free precession in nuclear magnetic resonance experiments. Phys Rev 94:630&#x2013;638 </citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meiboom</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gill</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Modified spin-echo method for measuring nuclear relaxation times</article-title>
          <source>Rev Sci Instrum</source>
          <year>1958</year>
          <volume>29</volume>
          <fpage>688</fpage>
          <lpage>691</lpage>
        </citation>
        <citation citation-type="display-unstructured">Meiboom S, Gill D (1958) Modified spin-echo method for measuring nuclear relaxation times. Rev Sci Instrum 29:688&#x2013;691 </citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>In den Kleef</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Cuppen</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>RLSQ: T1, T2, and rho calculations, combining ratios and least squares</article-title>
          <source>Magn Reson Med</source>
          <year>1987</year>
          <volume>5</volume>
          <fpage>513</fpage>
          <lpage>524</lpage>
        </citation>
        <citation citation-type="display-unstructured">In den Kleef JJ, Cuppen JJ (1987) RLSQ: T1, T2, and rho calculations, combining ratios and least squares. Magn Reson Med 5:513&#x2013;524 <pub-id pub-id-type="pmid">3437812</pub-id></citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Holden</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload</article-title>
          <source>Eur Heart J</source>
          <year>2001</year>
          <volume>22</volume>
          <fpage>2171</fpage>
          <lpage>2179</lpage>
        </citation>
        <citation citation-type="display-unstructured">Anderson LJ, Holden S, Davis B et al (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22:2171&#x2013;2179 <pub-id pub-id-type="pmid">11913479</pub-id></citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wood</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Tyszka</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Carson</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease</article-title>
          <source>Blood</source>
          <year>2004</year>
          <volume>103</volume>
          <fpage>1934</fpage>
          <lpage>1936</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wood JC, Tyszka JM, Carson S et al (2004) Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 103:1934&#x2013;1936 <pub-id pub-id-type="pmid">14630822</pub-id></citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jensen</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>FT</given-names>
            </name>
            <name>
              <surname>Christensen</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool</article-title>
          <source>Blood</source>
          <year>2003</year>
          <volume>101</volume>
          <fpage>4632</fpage>
          <lpage>4639</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jensen PD, Jensen FT, Christensen T et al (2003) Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood 101:4632&#x2013;4639 <pub-id pub-id-type="pmid">12576333</pub-id></citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Westwood</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Firmin</surname>
              <given-names>DN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia</article-title>
          <source>J Magn Reson Imaging</source>
          <year>2003</year>
          <volume>18</volume>
          <fpage>616</fpage>
          <lpage>620</lpage>
        </citation>
        <citation citation-type="display-unstructured">Westwood MA, Anderson LJ, Firmin DN et al (2003) Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging 18:616&#x2013;620 <pub-id pub-id-type="pmid">14579406</pub-id></citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gorell</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Ordidge</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>GG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Increased iron-related MRI contrast in the substantia nigra in Parkinson&#x2019;s disease</article-title>
          <source>Neurology</source>
          <year>1995</year>
          <volume>45</volume>
          <fpage>1138</fpage>
          <lpage>1143</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gorell JM, Ordidge RJ, Brown GG et al (1995) Increased iron-related MRI contrast in the substantia nigra in Parkinson&#x2019;s disease. Neurology 45:1138&#x2013;1143 <pub-id pub-id-type="pmid">7783878</pub-id></citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ordidge</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Gorell</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Deniau</surname>
              <given-names>JC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla</article-title>
          <source>Magn Reson Med</source>
          <year>1994</year>
          <volume>32</volume>
          <fpage>335</fpage>
          <lpage>341</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ordidge RJ, Gorell JM, Deniau JC et al (1994) Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Magn Reson Med 32:335&#x2013;341 <pub-id pub-id-type="pmid">7984066</pub-id></citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wacker</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Bock</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hartlep</surname>
              <given-names>AW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Changes in myocardial oxygenation and perfusion under pharmacological stress with dipyridamole: assessment using T*2 and T1 measurements</article-title>
          <source>Magn Reson Med</source>
          <year>1999</year>
          <volume>41</volume>
          <fpage>686</fpage>
          <lpage>695</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wacker CM, Bock M, Hartlep AW et al (1999) Changes in myocardial oxygenation and perfusion under pharmacological stress with dipyridamole: assessment using T*2 and T1 measurements. Magn Reson Med 41:686&#x2013;695 <pub-id pub-id-type="pmid">10332843</pub-id></citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>St Pierre</surname>
              <given-names>TG</given-names>
            </name>
          </person-group>
          <article-title>Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility</article-title>
          <source>Lancet</source>
          <year>2003</year>
          <volume>361</volume>
          <fpage>182</fpage>
        </citation>
        <citation citation-type="display-unstructured">St Pierre TG (2003) Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility. Lancet 361:182; author reply 183&#x2013;184 <pub-id pub-id-type="pmid">12531617</pub-id></citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bauer</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Nadler</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Bock</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Theory of the bold effect in the capillary region: an analytical approach for the determination of T2 in the capillary network of myocardium</article-title>
          <source>Magn Reson Med</source>
          <year>1999</year>
          <volume>41</volume>
          <fpage>51</fpage>
          <lpage>62</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bauer WR, Nadler W, Bock M et al (1999) Theory of the bold effect in the capillary region: an analytical approach for the determination of T2 in the capillary network of myocardium. Magn Reson Med 41:51&#x2013;62 <pub-id pub-id-type="pmid">10025611</pub-id></citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Papakonstantinou</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Kostaridou</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Maris</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Quantification of liver iron overload by T2 quantitative magnetic resonance imaging in thalassemia: impact of chronic hepatitis C on measurements</article-title>
          <source>J Pediatr Hematol Oncol</source>
          <year>1999</year>
          <volume>21</volume>
          <fpage>142</fpage>
          <lpage>148</lpage>
        </citation>
        <citation citation-type="display-unstructured">Papakonstantinou O, Kostaridou S, Maris T et al (1999) Quantification of liver iron overload by T2 quantitative magnetic resonance imaging in thalassemia: impact of chronic hepatitis C on measurements. J Pediatr Hematol Oncol 21:142&#x2013;148 <pub-id pub-id-type="pmid">10206461</pub-id></citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>St Pierre</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Tran</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Organ-specific crystalline structures of ferritin cores in beta-thalassemia/hemoglobin E</article-title>
          <source>Biol Met</source>
          <year>1991</year>
          <volume>4</volume>
          <fpage>162</fpage>
          <lpage>165</lpage>
        </citation>
        <citation citation-type="display-unstructured">St Pierre TG, Tran KC, Webb J et al (1991) Organ-specific crystalline structures of ferritin cores in beta-thalassemia/hemoglobin E. Biol Met 4:162&#x2013;165 <pub-id pub-id-type="pmid">1931435</pub-id></citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ladis</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Chouliaras</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Berdousi</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Longitudinal study of survival and causes of death in patients with thalassemia major in Greece</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>2005</year>
          <volume>1054</volume>
          <fpage>445</fpage>
          <lpage>450</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ladis V, Chouliaras G, Berdousi H et al (2005) Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Ann N Y Acad Sci 1054:445&#x2013;450 <pub-id pub-id-type="pmid">16339695</pub-id></citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kattamis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kassou</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Berdousi</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion</article-title>
          <source>Haematologica</source>
          <year>2003</year>
          <volume>88</volume>
          <fpage>1423</fpage>
          <lpage>1425</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kattamis A, Kassou C, Berdousi H et al (2003) Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion. Haematologica 88:1423&#x2013;1425 <pub-id pub-id-type="pmid">14687998</pub-id></citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christoforidis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Haritandi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Perifanis</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major</article-title>
          <source>Eur J Radiol</source>
          <year>2007</year>
          <volume>62</volume>
          <fpage>138</fpage>
          <lpage>142</lpage>
        </citation>
        <citation citation-type="display-unstructured">Christoforidis A, Haritandi A, Perifanis V et al (2007) MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major. Eur J Radiol 62:138&#x2013;142 <pub-id pub-id-type="pmid">17161570</pub-id></citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christoforidis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Haritandi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tsatra</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Four-year evaluation of myocardial and liver iron assessed prospectively with serial MRI scans in young patients with beta-thalassaemia major: comparison between different chelation regimens</article-title>
          <source>Eur J Haematol</source>
          <year>2007</year>
          <volume>78</volume>
          <fpage>52</fpage>
          <lpage>57</lpage>
        </citation>
        <citation citation-type="display-unstructured">Christoforidis A, Haritandi A, Tsatra I et al (2007) Four-year evaluation of myocardial and liver iron assessed prospectively with serial MRI scans in young patients with beta-thalassaemia major: comparison between different chelation regimens. Eur J Haematol 78:52&#x2013;57 <pub-id pub-id-type="pmid">17042760</pub-id></citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sparacia</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Iaia</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Banco</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transfusional hemochromatosis: quantitative relation of MR imaging pituitary signal intensity reduction to hypogonadotropic hypogonadism</article-title>
          <source>Radiology</source>
          <year>2000</year>
          <volume>215</volume>
          <fpage>818</fpage>
          <lpage>823</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sparacia G, Iaia A, Banco A et al (2000) Transfusional hemochromatosis: quantitative relation of MR imaging pituitary signal intensity reduction to hypogonadotropic hypogonadism. Radiology 215:818&#x2013;823 <pub-id pub-id-type="pmid">10831704</pub-id></citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <citation citation-type="other">Argyropoulou MI, Kiortsis DN, Astrakas L et al (2007) Liver, bone marrow, pancreas and pituitary gland iron overload in young and adult thalassemic patients: a T2 relaxometry study. Eur Radiol. DOI 10.1007/s00330-007-0683-1</citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wood</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Enriquez</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ghugre</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients</article-title>
          <source>Blood</source>
          <year>2005</year>
          <volume>106</volume>
          <fpage>1460</fpage>
          <lpage>1465</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wood JC, Enriquez C, Ghugre N et al (2005) MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106:1460&#x2013;1465 <pub-id pub-id-type="pmid">15860670</pub-id></citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aldouri</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Wonke</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hoffbrand</surname>
              <given-names>AV</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine</article-title>
          <source>J Clin Pathol</source>
          <year>1987</year>
          <volume>40</volume>
          <fpage>1353</fpage>
          <lpage>1359</lpage>
        </citation>
        <citation citation-type="display-unstructured">Aldouri MA, Wonke B, Hoffbrand AV et al (1987) Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine. J Clin Pathol 40:1353&#x2013;1359 <pub-id pub-id-type="pmid">3121679</pub-id></citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drakonaki</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Papakonstantinou</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Maris</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adrenal glands in beta-thalassemia major: magnetic resonance (MR) imaging features and correlation with iron stores</article-title>
          <source>Eur Radiol</source>
          <year>2005</year>
          <volume>15</volume>
          <fpage>2462</fpage>
          <lpage>2468</lpage>
        </citation>
        <citation citation-type="display-unstructured">Drakonaki E, Papakonstantinou O, Maris T et al (2005) Adrenal glands in beta-thalassemia major: magnetic resonance (MR) imaging features and correlation with iron stores. Eur Radiol 15:2462&#x2013;2468 <pub-id pub-id-type="pmid">16086182</pub-id></citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <citation citation-type="other">Kushner JP, Porter JP, Olivieri NF (2001) Secondary iron overload. Hematology Am Soc Hematol Educ Program 47&#x2013;61</citation>
      </ref>
      <ref id="CR89">
        <label>89.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gatter</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Trowbridge</surname>
              <given-names>IS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transferrin receptors in human tissues: their distribution and possible clinical relevance</article-title>
          <source>J Clin Pathol</source>
          <year>1983</year>
          <volume>36</volume>
          <fpage>539</fpage>
          <lpage>545</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gatter KC, Brown G, Trowbridge IS et al (1983) Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol 36:539&#x2013;545 <pub-id pub-id-type="pmid">6302135</pub-id></citation>
      </ref>
      <ref id="CR90">
        <label>90.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Atkin</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Burnett</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>VL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Expression of the transferrin receptor in human anterior pituitary adenomas is confined to gonadotrophinomas</article-title>
          <source>Clin Endocrinol (Oxf)</source>
          <year>1996</year>
          <volume>44</volume>
          <fpage>467</fpage>
          <lpage>471</lpage>
        </citation>
        <citation citation-type="display-unstructured">Atkin SL, Burnett HE, Green VL et al (1996) Expression of the transferrin receptor in human anterior pituitary adenomas is confined to gonadotrophinomas. Clin Endocrinol (Oxf) 44:467&#x2013;471 <pub-id pub-id-type="pmid">8706315</pub-id></citation>
      </ref>
      <ref id="CR91">
        <label>91.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thorstensen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Trinder</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zak</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Uptake of iron from N-terminal half-transferrin by isolated rat hepatocytes. Evidence of transferrin-receptor-independent iron uptake</article-title>
          <source>Eur J Biochem</source>
          <year>1995</year>
          <volume>232</volume>
          <fpage>129</fpage>
          <lpage>133</lpage>
        </citation>
        <citation citation-type="display-unstructured">Thorstensen K, Trinder D, Zak O et al (1995) Uptake of iron from N-terminal half-transferrin by isolated rat hepatocytes. Evidence of transferrin-receptor-independent iron uptake. Eur J Biochem 232:129&#x2013;133 <pub-id pub-id-type="pmid">7556141</pub-id></citation>
      </ref>
      <ref id="CR92">
        <label>92.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barry</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Flynn</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Letsky</surname>
              <given-names>EA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long-term chelation therapy in thalassaemia major: effect on liver iron concentration, liver histology, and clinical progress</article-title>
          <source>Br Med J</source>
          <year>1974</year>
          <volume>2</volume>
          <fpage>16</fpage>
          <lpage>20</lpage>
        </citation>
        <citation citation-type="display-unstructured">Barry M, Flynn DM, Letsky EA et al (1974) Long-term chelation therapy in thalassaemia major: effect on liver iron concentration, liver histology, and clinical progress. Br Med J 2:16&#x2013;20 <pub-id pub-id-type="pmid">4821036</pub-id></citation>
      </ref>
      <ref id="CR93">
        <label>93.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cohen</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Management of iron overload in the pediatric patient</article-title>
          <source>Hematol Oncol Clin North Am</source>
          <year>1987</year>
          <volume>1</volume>
          <fpage>521</fpage>
          <lpage>544</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cohen A (1987) Management of iron overload in the pediatric patient. Hematol Oncol Clin North Am 1:521&#x2013;544 <pub-id pub-id-type="pmid">3329185</pub-id></citation>
      </ref>
      <ref id="CR94">
        <label>94.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zurlo</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Stefano</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Borgna-Pignatti</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Survival and causes of death in thalassaemia major</article-title>
          <source>Lancet</source>
          <year>1989</year>
          <volume>2</volume>
          <fpage>27</fpage>
          <lpage>30</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zurlo MG, De Stefano P, Borgna-Pignatti C et al (1989) Survival and causes of death in thalassaemia major. Lancet 2:27&#x2013;30 <pub-id pub-id-type="pmid">2567801</pub-id></citation>
      </ref>
      <ref id="CR95">
        <label>95.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borgna-Pignatti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rugolotto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nobili</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A trial of high-dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in childhood</article-title>
          <source>J Pediatr</source>
          <year>1997</year>
          <volume>130</volume>
          <fpage>13</fpage>
          <lpage>16</lpage>
        </citation>
        <citation citation-type="display-unstructured">Borgna-Pignatti C, Rugolotto S, Nobili B et al (1997) A trial of high-dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in childhood. J Pediatr 130:13&#x2013;16 <pub-id pub-id-type="pmid">9003845</pub-id></citation>
      </ref>
      <ref id="CR96">
        <label>96.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mavrogeni</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Gotsis</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Markussis</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>T2 relaxation time study of iron overload in b-thalassemia</article-title>
          <source>Magma</source>
          <year>1998</year>
          <volume>6</volume>
          <fpage>7</fpage>
          <lpage>12</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mavrogeni SI, Gotsis ED, Markussis V et al (1998) T2 relaxation time study of iron overload in b-thalassemia. Magma 6:7&#x2013;12 <pub-id pub-id-type="pmid">9794284</pub-id></citation>
      </ref>
      <ref id="CR97">
        <label>97.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jensen</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>FT</given-names>
            </name>
            <name>
              <surname>Christensen</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload</article-title>
          <source>Magma</source>
          <year>2001</year>
          <volume>12</volume>
          <fpage>153</fpage>
          <lpage>166</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jensen PD, Jensen FT, Christensen T et al (2001) Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload. Magma 12:153&#x2013;166 <pub-id pub-id-type="pmid">11390271</pub-id></citation>
      </ref>
      <ref id="CR98">
        <label>98.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>He</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gatehouse</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>LJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Development of a novel optimized breathhold technique for myocardial T2 measurement in thalassemia</article-title>
          <source>J Magn Reson Imaging</source>
          <year>2006</year>
          <volume>24</volume>
          <fpage>580</fpage>
          <lpage>585</lpage>
        </citation>
        <citation citation-type="display-unstructured">He T, Gatehouse PD, Anderson LJ et al (2006) Development of a novel optimized breathhold technique for myocardial T2 measurement in thalassemia. J Magn Reson Imaging 24:580&#x2013;585 <pub-id pub-id-type="pmid">16892203</pub-id></citation>
      </ref>
      <ref id="CR99">
        <label>99.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Economou-Petersen</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Aessopos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kladi</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Apolipoprotein E epsilon4 allele as a genetic risk factor for left ventricular failure in homozygous beta-thalassemia</article-title>
          <source>Blood</source>
          <year>1998</year>
          <volume>92</volume>
          <fpage>3455</fpage>
          <lpage>3459</lpage>
        </citation>
        <citation citation-type="display-unstructured">Economou-Petersen E, Aessopos A, Kladi A et al (1998) Apolipoprotein E epsilon4 allele as a genetic risk factor for left ventricular failure in homozygous beta-thalassemia. Blood 92:3455&#x2013;3459 <pub-id pub-id-type="pmid">9787187</pub-id></citation>
      </ref>
      <ref id="CR100">
        <label>100.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferrara</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Matarese</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Francese</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Role of apolipoprotein E (APOE) polymorphism on left cardiac failure in homozygous beta thalassaemic patients</article-title>
          <source>Br J Haematol</source>
          <year>2001</year>
          <volume>114</volume>
          <fpage>959</fpage>
          <lpage>960</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ferrara M, Matarese SM, Francese M et al (2001) Role of apolipoprotein E (APOE) polymorphism on left cardiac failure in homozygous beta thalassaemic patients. Br J Haematol 114:959&#x2013;960 <pub-id pub-id-type="pmid">11564097</pub-id></citation>
      </ref>
      <ref id="CR101">
        <label>101.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olson</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>McCall</surname>
              <given-names>JT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy</article-title>
          <source>J Am Coll Cardiol</source>
          <year>1987</year>
          <volume>10</volume>
          <fpage>1239</fpage>
          <lpage>1243</lpage>
        </citation>
        <citation citation-type="display-unstructured">Olson LJ, Edwards WD, McCall JT et al (1987) Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy. J Am Coll Cardiol 10:1239&#x2013;1243 <pub-id pub-id-type="pmid">3680791</pub-id></citation>
      </ref>
      <ref id="CR102">
        <label>102.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bergeron</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kovacs</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Pituitary siderosis. A histologic, immunocytologic, and ultrastructural study</article-title>
          <source>Am J Pathol</source>
          <year>1978</year>
          <volume>93</volume>
          <fpage>295</fpage>
          <lpage>309</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bergeron C, Kovacs K (1978) Pituitary siderosis. A histologic, immunocytologic, and ultrastructural study. Am J Pathol 93:295&#x2013;309 <pub-id pub-id-type="pmid">362939</pub-id></citation>
      </ref>
      <ref id="CR103">
        <label>103.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oerter</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Kamp</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Munson</surname>
              <given-names>PJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multiple hormone deficiencies in children with hemochromatosis</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>1993</year>
          <volume>76</volume>
          <fpage>357</fpage>
          <lpage>361</lpage>
        </citation>
        <citation citation-type="display-unstructured">Oerter KE, Kamp GA, Munson PJ et al (1993) Multiple hormone deficiencies in children with hemochromatosis. J Clin Endocrinol Metab 76:357&#x2013;361 <pub-id pub-id-type="pmid">8432779</pub-id></citation>
      </ref>
      <ref id="CR104">
        <label>104.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Argyropoulou</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Kiortsis</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Metafratzi</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pituitary gland height evaluated by MR in patients with beta-thalassemia major: a marker of pituitary gland function</article-title>
          <source>Neuroradiology</source>
          <year>2001</year>
          <volume>43</volume>
          <fpage>1056</fpage>
          <lpage>1058</lpage>
        </citation>
        <citation citation-type="display-unstructured">Argyropoulou MI, Kiortsis DN, Metafratzi Z et al (2001) Pituitary gland height evaluated by MR in patients with beta-thalassemia major: a marker of pituitary gland function. Neuroradiology 43:1056&#x2013;1058 <pub-id pub-id-type="pmid">11792043</pub-id></citation>
      </ref>
      <ref id="CR105">
        <label>105.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sparacia</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Midiri</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>D&#x2019;Angelo</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Magnetic resonance imaging of the pituitary gland in patients with secondary hypogonadism due to transfusional hemochromatosis</article-title>
          <source>Magma</source>
          <year>1999</year>
          <volume>8</volume>
          <fpage>87</fpage>
          <lpage>90</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sparacia G, Midiri M, D&#x2019;Angelo P et al (1999) Magnetic resonance imaging of the pituitary gland in patients with secondary hypogonadism due to transfusional hemochromatosis. Magma 8:87&#x2013;90 <pub-id pub-id-type="pmid">10456370</pub-id></citation>
      </ref>
      <ref id="CR106">
        <label>106.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Metafratzi</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Argyropoulou</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Kiortsis</surname>
              <given-names>DN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>T(2) relaxation rate of basal ganglia and cortex in patients with beta-thalassaemia major</article-title>
          <source>Br J Radiol</source>
          <year>2001</year>
          <volume>74</volume>
          <fpage>407</fpage>
          <lpage>410</lpage>
        </citation>
        <citation citation-type="display-unstructured">Metafratzi Z, Argyropoulou MI, Kiortsis DN et al (2001) T(2) relaxation rate of basal ganglia and cortex in patients with beta-thalassaemia major. Br J Radiol 74:407&#x2013;410 <pub-id pub-id-type="pmid">11388988</pub-id></citation>
      </ref>
      <ref id="CR107">
        <label>107.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kattamis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ladis</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Tsoussis</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evolution of glucose intolerance and diabetes in transfused patients with thalassemia</article-title>
          <source>Pediatr Endocrinol Rev</source>
          <year>2004</year>
          <volume>2</volume>
          <issue>Suppl 2</issue>
          <fpage>267</fpage>
          <lpage>271</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kattamis C, Ladis V, Tsoussis D et al (2004) Evolution of glucose intolerance and diabetes in transfused patients with thalassemia. Pediatr Endocrinol Rev 2 [Suppl 2]:267&#x2013;271 <pub-id pub-id-type="pmid">16462709</pub-id></citation>
      </ref>
      <ref id="CR108">
        <label>108.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gullo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Corcioni</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Brancati</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Morphologic and functional evaluation of the exocrine pancreas in beta-thalassemia major</article-title>
          <source>Pancreas</source>
          <year>1993</year>
          <volume>8</volume>
          <fpage>176</fpage>
          <lpage>180</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gullo L, Corcioni E, Brancati C et al (1993) Morphologic and functional evaluation of the exocrine pancreas in beta-thalassemia major. Pancreas 8:176&#x2013;180 <pub-id pub-id-type="pmid">8460093</pub-id></citation>
      </ref>
      <ref id="CR109">
        <label>109.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Midiri</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lo Casto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sparacia</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MR imaging of pancreatic changes in patients with transfusion-dependent beta-thalassemia major</article-title>
          <source>AJR</source>
          <year>1999</year>
          <volume>173</volume>
          <fpage>187</fpage>
          <lpage>192</lpage>
        </citation>
        <citation citation-type="display-unstructured">Midiri M, Lo Casto A, Sparacia G et al (1999) MR imaging of pancreatic changes in patients with transfusion-dependent beta-thalassemia major. AJR 173:187&#x2013;192 <pub-id pub-id-type="pmid">10397124</pub-id></citation>
      </ref>
      <ref id="CR110">
        <label>110.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martins</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Picanco</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Fonseca</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The role of HFE mutations on iron metabolism in beta-thalassemia carriers</article-title>
          <source>J Hum Genet</source>
          <year>2004</year>
          <volume>49</volume>
          <fpage>651</fpage>
          <lpage>655</lpage>
        </citation>
        <citation citation-type="display-unstructured">Martins R, Picanco I, Fonseca A et al (2004) The role of HFE mutations on iron metabolism in beta-thalassemia carriers. J Hum Genet 49:651&#x2013;655 <pub-id pub-id-type="pmid">15538648</pub-id></citation>
      </ref>
      <ref id="CR111">
        <label>111.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katz</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <article-title>Splenic extramedullary hematopoiesis: large focal lesion in a patient with thalassemia</article-title>
          <source>AJR</source>
          <year>1999</year>
          <volume>173</volume>
          <fpage>1715</fpage>
          <lpage>1716</lpage>
        </citation>
        <citation citation-type="display-unstructured">Katz DS (1999) Splenic extramedullary hematopoiesis: large focal lesion in a patient with thalassemia. AJR 173:1715&#x2013;1716 <pub-id pub-id-type="pmid">10584831</pub-id></citation>
      </ref>
      <ref id="CR112">
        <label>112.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Argyropoulou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Perignon</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Brunelle</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Height of normal pituitary gland as a function of age evaluated by magnetic resonance imaging in children</article-title>
          <source>Pediatr Radiol</source>
          <year>1991</year>
          <volume>21</volume>
          <fpage>247</fpage>
          <lpage>249</lpage>
        </citation>
        <citation citation-type="display-unstructured">Argyropoulou M, Perignon F, Brunelle F et al (1991) Height of normal pituitary gland as a function of age evaluated by magnetic resonance imaging in children. Pediatr Radiol 21:247&#x2013;249 <pub-id pub-id-type="pmid">1870916</pub-id></citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>